search
Back to results

Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room (OpenCPAP-DR)

Primary Purpose

Respiratory Distress Syndrome in Premature Infant, Non-invasive Ventilation, Lung Injury

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
openCPAP
standardCPAP
Sponsored by
Dokuz Eylul University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Distress Syndrome in Premature Infant focused on measuring nasal CPAP, delivery room, open lung strategy, PEEP, Respiratory Distress Syndrome, Individualised ventilation

Eligibility Criteria

1 Minute - 2 Minutes (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Infants born before 30 completed weeks of gestation and received early nCPAP immediately after birth in delivery room

Exclusion Criteria:

  • Requirement of surfactant or endotracheal intubation or positive pressure ventilation before the completion of interventions
  • Major congenital anomaly
  • Transportation to another hospital

Sites / Locations

  • Etlik Zubeyde Hanım Maternity and Children Hospital
  • Dokuz Eylul University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

openCPAP

standardCPAP

Arm Description

Immediately after birth, early nCPAP will be started with a nasal mask with a T-piece resuscitator with 8 cm H2O pressure and 0.30 fiO2. The heart rate (HR) and preductal saturation (SpO2) will be evaluated every 30 seconds. Individually, the following steps will be done according to the situation: If the HR > 120 / min and SpO2 not measured yet or be in the target range: The pressure will be continue as 8 cmH2O. If the HR between 100-120 but SpO2 below the target range or not measured yet : First the pressure will be increased to 10 cm H2O; than fiO2 will be increased gradually if the patient will not respond to 10 cmH2O pressure. Pressure will be reduced to 8 cmH2O if the HR remains> 120 / min and oxygen requirement <0.30 for more than 60 seconds.

Immediately after birth, early nCPAP will be started with a nasal mask with T-piece resuscitator at 6 cmH2O pressure and 0.30 fiO2. HR and preductal saturation will be evaluated every 30 seconds. The following steps will be performed according to the situation: If the HR > 120 / min and SpO2 be in the target range or not measurable yet: The pressure will be continue as 6 cmH2O. If the HR between 100-120 but SpO2 below the target range or not measured yet : The pressure will increased up to 8 cm H2O. FiO2 will be increased gradually if the patient will not respond to 8 cmH2O pressure. Pressure will be reduced to 6 cmH2O if the HR remains> 120 / min and oxygen requirement <0.30 for more than 60 seconds.

Outcomes

Primary Outcome Measures

Incidence of invasive mechanical ventilation
Need for intubation and mechanical ventilation (MV) Need for intubation and mechanical ventilation (MV)
Incidence of Surfactant therapy
Surfactant therapy requirement
SpO2 at 5th minute
The oxygen saturation of the blood at 5 th minute
SpO2 at 10th minute
The oxygen saturation of the blood at 10 th minute

Secondary Outcome Measures

Incidence of pneumothorax
Incidence of pneumothorax during intervention and within 24 hours
Incidence ofIVH (Grade 3-4)
Intraventricular hemorrhage (IVH)
Duration of ventilatory support (non-invasive)
Duration of non-invasive MV (days)
Duration of invasive ventilatory support
Duration of invasive MV ( days)
Duration of oxygen (O2)
Duration of O2 treatment (days)
Incidence of Surfactant treatment
Mean number of surfactant treatment
Bronchopulmonary dysplasia (BPD)
Incidence of BPD
Mortality
Death or composite outcome death/BPD

Full Information

First Posted
August 17, 2021
Last Updated
May 9, 2023
Sponsor
Dokuz Eylul University
Collaborators
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05031650
Brief Title
Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room
Acronym
OpenCPAP-DR
Official Title
Can Open Lung Strategy During Non-Invasive Respiratory Support of Very Premature Infants in the Delivery Room Reduce Non-Invasive Ventilation Failure Compared With Standard Approach? A Randomised Controlled Multicentric Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
July 1, 2019 (Actual)
Primary Completion Date
December 31, 2022 (Actual)
Study Completion Date
March 1, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Dokuz Eylul University
Collaborators
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The opening and aeration of the lung is critical for a successful transition from fetal to neonatal life. Early nasal CPAP in the delivery room in spontaneously breathing premature babies with a gestational age of 30 weeks or less is a standard treatment approach since it reduces the need for invasive mechanical ventilation and surfactant therapy. In respiratory distress syndrome (RDS) management, providing optimal lung volumes in the very early period from the beginning of delivery room approaches probably augments the expected lung protective effect. Although the benefits of CPAP support are well known, standart CPAP pressures recommended in the guidelines may not meet the needs of individual babies. Maintaining lung patency in the delivery room is the main mechanism of action of CPAP and the requirement may vary individually depending on lung physiology. In this multicenter randomized controlled study, we aimed to compare the effects of CPAP therapy applied with a personalized open lung strategy (openCPAP), and standard CPAP therapy (standardCPAP) on oxygenation, respiratory support need and surfactant treatment requirement in preterm babies with RDS in the delivery room.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Distress Syndrome in Premature Infant, Non-invasive Ventilation, Lung Injury
Keywords
nasal CPAP, delivery room, open lung strategy, PEEP, Respiratory Distress Syndrome, Individualised ventilation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
145 (Actual)

8. Arms, Groups, and Interventions

Arm Title
openCPAP
Arm Type
Active Comparator
Arm Description
Immediately after birth, early nCPAP will be started with a nasal mask with a T-piece resuscitator with 8 cm H2O pressure and 0.30 fiO2. The heart rate (HR) and preductal saturation (SpO2) will be evaluated every 30 seconds. Individually, the following steps will be done according to the situation: If the HR > 120 / min and SpO2 not measured yet or be in the target range: The pressure will be continue as 8 cmH2O. If the HR between 100-120 but SpO2 below the target range or not measured yet : First the pressure will be increased to 10 cm H2O; than fiO2 will be increased gradually if the patient will not respond to 10 cmH2O pressure. Pressure will be reduced to 8 cmH2O if the HR remains> 120 / min and oxygen requirement <0.30 for more than 60 seconds.
Arm Title
standardCPAP
Arm Type
Active Comparator
Arm Description
Immediately after birth, early nCPAP will be started with a nasal mask with T-piece resuscitator at 6 cmH2O pressure and 0.30 fiO2. HR and preductal saturation will be evaluated every 30 seconds. The following steps will be performed according to the situation: If the HR > 120 / min and SpO2 be in the target range or not measurable yet: The pressure will be continue as 6 cmH2O. If the HR between 100-120 but SpO2 below the target range or not measured yet : The pressure will increased up to 8 cm H2O. FiO2 will be increased gradually if the patient will not respond to 8 cmH2O pressure. Pressure will be reduced to 6 cmH2O if the HR remains> 120 / min and oxygen requirement <0.30 for more than 60 seconds.
Intervention Type
Procedure
Intervention Name(s)
openCPAP
Intervention Description
Randomized to : Individualized high level CPAP between 8-10 cmH2O pressure
Intervention Type
Procedure
Intervention Name(s)
standardCPAP
Intervention Description
Randomized to : Standard level CPAP between 6-8 cmH2O pressure
Primary Outcome Measure Information:
Title
Incidence of invasive mechanical ventilation
Description
Need for intubation and mechanical ventilation (MV) Need for intubation and mechanical ventilation (MV)
Time Frame
First 72 hours after the intervention
Title
Incidence of Surfactant therapy
Description
Surfactant therapy requirement
Time Frame
First 72 hours after the intervention
Title
SpO2 at 5th minute
Description
The oxygen saturation of the blood at 5 th minute
Time Frame
5 minute after the delivery
Title
SpO2 at 10th minute
Description
The oxygen saturation of the blood at 10 th minute
Time Frame
5 minute after the delivery
Secondary Outcome Measure Information:
Title
Incidence of pneumothorax
Description
Incidence of pneumothorax during intervention and within 24 hours
Time Frame
First 24 hours after the intervention
Title
Incidence ofIVH (Grade 3-4)
Description
Intraventricular hemorrhage (IVH)
Time Frame
First 72 hours after the intervention
Title
Duration of ventilatory support (non-invasive)
Description
Duration of non-invasive MV (days)
Time Frame
During first hospitalisation ( an average of 10 weeks)
Title
Duration of invasive ventilatory support
Description
Duration of invasive MV ( days)
Time Frame
During first hospitalisation ( an average of 10 weeks)
Title
Duration of oxygen (O2)
Description
Duration of O2 treatment (days)
Time Frame
During hospitalisation ( an average of 10 weeks)
Title
Incidence of Surfactant treatment
Description
Mean number of surfactant treatment
Time Frame
During hospitalisation (an average of 10 weeks)
Title
Bronchopulmonary dysplasia (BPD)
Description
Incidence of BPD
Time Frame
At 36th postnatal week or discharge (an average of 10 weeks after intervention ) whichever came first
Title
Mortality
Description
Death or composite outcome death/BPD
Time Frame
through study completion (an average of 10 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Minute
Maximum Age & Unit of Time
2 Minutes
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Infants born before 30 completed weeks of gestation and received early nCPAP immediately after birth in delivery room Exclusion Criteria: Requirement of surfactant or endotracheal intubation or positive pressure ventilation before the completion of interventions Major congenital anomaly Transportation to another hospital
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hasan Ozkan, Prof.
Organizational Affiliation
Dokuz Eylül University- Faculty of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Nuray Duman, Prof.
Organizational Affiliation
Dokuz Eylül University- Faculty of Medicine
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Funda Tuzun, Assoc.Prof.
Organizational Affiliation
Dokuz Eylül University- Faculty of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Etlik Zubeyde Hanım Maternity and Children Hospital
City
Ankara
Country
Turkey
Facility Name
Dokuz Eylul University
City
İzmir
ZIP/Postal Code
35340
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room

We'll reach out to this number within 24 hrs